134 related articles for article (PubMed ID: 20973102)
1. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.
Kumar R; Khan SP; Joshi DD; Shaw GR; Ketterling RP; Feldman AL
Pediatr Blood Cancer; 2011 Feb; 56(2):307-10. PubMed ID: 20973102
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
3. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
[TBL] [Abstract][Full Text] [Related]
4. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases.
McClure R; Khoury J; Feldman A; Ketterling R
Leuk Res; 2010 Feb; 34(2):e71-3. PubMed ID: 19744706
[No Abstract] [Full Text] [Related]
5. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
7. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case.
Kim HJ; Woo HY; Koo HH; Tak EY; Kim SH
Am J Hematol; 2004 Aug; 76(4):360-3. PubMed ID: 15282669
[TBL] [Abstract][Full Text] [Related]
8. Hyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemia.
Healey K; Gray SL; Halligan GE; McKenzie AS; de Chadarévian JP; Morrissette JJ
Cancer Genet Cytogenet; 2009 Apr; 190(2):121-4. PubMed ID: 19380031
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
Beverloo HB
Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
[No Abstract] [Full Text] [Related]
10. Deletions of the p16 gene in pediatric leukemia and corresponding cell lines.
Kees UR; Ranford PR; Hatzis M
Oncogene; 1996 May; 12(10):2235-9. PubMed ID: 8668350
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13·2;q11·2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation.
Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
Br J Haematol; 2012 Nov; 159(4):488-91. PubMed ID: 22994152
[No Abstract] [Full Text] [Related]
12. Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients.
Bleeke M; Johann P; Gröbner S; Alten J; Cario G; Schäfer H; Klapper W; Khoury J; Pfister S; Müller I
Pediatr Blood Cancer; 2020 Feb; 67(2):e28074. PubMed ID: 31737984
[TBL] [Abstract][Full Text] [Related]
13. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
14. Primary Central Nervous System Histiocytic Sarcoma Arising After Precursor B-Cell Acute Lymphoblastic Leukemia.
Brown AF; Fan H; Floyd JR; Henry JM; Higgins RA
J Neuropathol Exp Neurol; 2015 Dec; 74(12):1120-6. PubMed ID: 26574666
[TBL] [Abstract][Full Text] [Related]
15. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas.
Chen W; Lau SK; Fong D; Wang J; Wang E; Arber DA; Weiss LM; Huang Q
Am J Surg Pathol; 2009 Jun; 33(6):863-73. PubMed ID: 19145200
[TBL] [Abstract][Full Text] [Related]
16. Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.
Alten J; Klapper W; Leuschner I; Eckert C; Beier R; Vallo E; Krause M; Claviez A; Vieth S; Bleckmann K; Möricke A; Schrappe M; Cario G
Pediatr Blood Cancer; 2015 Sep; 62(9):1656-60. PubMed ID: 25833113
[TBL] [Abstract][Full Text] [Related]
17. Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor.
Szinnai G; Cogliatti SB; Avoledo P; Dirnhofer S; Schmid U; Kühne T
Pediatr Blood Cancer; 2007 Dec; 49(7):1039-46. PubMed ID: 16572408
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia followed by a clonally-unrelated EBV-positive non-Hodgkin lymphoma and a clonally-related myelomonocytic leukemia cutis.
Szczepański T; de Vaan GA; Beishuizen A; Bogman J; Jansen MW; van Wering ER; van Dongen JJ
Pediatr Blood Cancer; 2004 Apr; 42(4):343-9. PubMed ID: 14966831
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.
Castro EC; Blazquez C; Boyd J; Correa H; de Chadarevian JP; Felgar RE; Graf N; Levy N; Lowe EJ; Manning JT; Proytcheva MA; Senger C; Shayan K; Sterba J; Werner A; Surti U; Jaffe R
Pediatr Dev Pathol; 2010; 13(3):225-37. PubMed ID: 19642834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
